Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2015, Vol. 11 ›› Issue (01): 86 -89. doi: 10.3877/cma.j.issn.1673-5250.2015.01.020

Special Issue:

Review

Research of polycystic ovary syndrome in proteomics

Li Li1, Jiangyu Zhang2, Xiaoqin Wang2, Hui Luo2, Huayuan Liu2, Jing Zhang2()   

  1. 1. Laboratory of Chinese Medicine Quality Research, Macau University of Science and Technology, Macau 00853, China; Department of Obstetrics and Gynecology, Guangdong Maternity and Child Health Hospital, Guangzhou Medical University, Guangzhou 510010, Guangdong Province, China
    2. Laboratory of Chinese Medicine Quality Research, Macau University of Science and Technology, Macau 00853, China
  • Received:2014-11-05 Revised:2014-12-10 Published:2015-02-01
  • Corresponding author: Jing Zhang
  • About author:
    Corresponding author: Zhang Jing, Email:

Polycystic ovary syndrome (PCOS) is a kind of disease with complex endocrine and metabolic disorder, which is characterized by ovulatory dysfunction, hyperandrogenism, hyperandrogenism performance or polycystic ovarian morphology.Among them, 50%-70% of PCOS patients are accompanied by insulin resistance and compensatory hyperinsulinemia disease.Currently, proteomics research is increasingly used in the diagnosis and treatment of PCOS. This article outlines the common usage of proteomics techniques, summarizes the current research of PCOS in proteomics from aspects of the pathogenesis, diagnostic markers and long-term complications and discusses the outlook of PCOS proteomics research.

[1]
Goodarzi MO,Dumesic DA,Chazenbalk G,et al.Polycystic ovary syndrome:etiology, pathogenesis and diagnosis[J].Nat Rev Endocrinol,2011,7 (4):219–231.
[2]
DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment[J]. Fertil Steril,2005,83(5):1454–1560.
[3]
Pasquali R,Stener-Victorin E, Yildiz BO,et al.PCOS forum: research in polycystic ovary syndrome today and tomorrow[J].Clin Endocrinol (Oxf),2011,74(4): 424–433.
[4]
Legro RS, Arslanian SA, Ehrmann DA,et al.Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013,98(12):4565–4592.
[5]
Hughes C, Elgasim M, Layfield R,et al.Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review[J]. Hum Reprod,2006,21(11): 2766–2775.
[6]
Swinbanks D.Government backs proteome proposal[J]. Nature,1995, 378(6558):653.
[7]
Weiss W, Görg A. High-resolution two-dimensional electrophoresis[J].Methods Mol Biol, 2009,564:13–32.
[8]
Görg A,Weiss W,Dunn MJ.Current two-dimensional electrophoresis technology for proteomics[J]. Proteomics,2004, 4(12): 3665–3685.
[9]
Gloerich J,Wexers RA, Smeitink JA,et al. Proteomic of approaches to study genetic and metabolic disorders[J]. J Proteome Res,2007,6(2):506–512.
[10]
Suss C,Solimena M.Proteomic profiling of beta-cells using a classical approach- two-dimensional gel electrophoresis[J].Exp Clin Endocrinol Diabetes,2008,116:13–20.
[11]
Wong SC, Chan CM, Ma BB,et al. Advanced proteomic technologies for cancer biomarker discovery[J]. Expert Rev Proteomics, 2009,6(2):123–134.
[12]
Wang H, Hanash S. Multi dimensional liquid phase based separations in proteomics[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2003,787(1):11–18.
[13]
Choi DH,Lee WS, Won M,et al. The apolipoprotein A-Ⅰ level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis[J]. J Proteome Res,2010, 9(9):4329–4336.
[14]
Chapman K.The ProteinChip Biomarker System from Ciphergen Biosystems:a novel proteomics platform for rapid biomarker discovery and validation[J]. Biochem Soc Trans,2002, 30(2):82–87.
[15]
Ma X, Fan L, Meng Y,et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome[J]. Mol Hum Reprod,2007, 13(8): 527–535.
[16]
Kim YS, Gu BH, Choi BC,et al. Apolipoprotein A-Ⅳ as a novel gene associated with polycystic ovary syndrome[J].Int J Mol Med,2013,31(3):707–716.
[17]
Dai G, Lu G. Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation[J]. Reprod Fertil Dev,2012,24(7): 893–904.
[18]
Corton M, Botella-Carretero JI, Lopez JA,et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry[J]. Hum Reprod,2008,23(3): 651–661.
[19]
Insenser M, Martinez-Garcia MA, Montes R,et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation[J]. J Clin Endocrinol Metab,2010,95(8): 3863–3870.
[20]
Montes-Nieto R, Insenser M,Martínez-García MÁ,et al.A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes[J]. J Clin Endocrinol Metab,2013,98(3): E576–E585.
[21]
Zhao S, Qiao J, Li M, et al.Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry[J]. Fertil Steril,2007,88(1): 145–151.
[22]
Liu JJ,Ma X,Cai LB, et al. Downregulation of both gene expression and activity of HSP 27 improved maturation of mouse oocyte in vitro[J]. Reprod Biol Endocrinol,2010, 8:47.
[23]
Insenser M, Martínez-García MA,Montes R,et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation[J]. J Clin Endocrinol Metab, 2010, 95(8):3863–3870.
[24]
Atiomo WU,Khalid S,Ziauddin A,et al.Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome[J].Expert Rev Proteomics,2009,6(5):469–499.
[25]
秦芬,丘彦,杨曦,等.多囊卵巢综合征差异蛋白质组分析[J].重庆医科大学学报,2010,35(1):22–24.
[26]
张丽静,丘彦.多囊卵巢综合征胰岛素抵抗差异蛋白的分析[J].重庆医科大学学报,2011,36(2):145–147.
[27]
Matharoo-Ball B, Hughes C,Lancashire L,et al.Characterization of biomarkers in polycystic ovary syndrome(PCOS) using multiple distinct proteomic platforms[J].J Proteome Res,2007,6(8): 3321–3328.
[28]
Galazis N, Afxentiou T, Xenophontos M,et al.Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome[J]. Eur J Endocrinol,2013,168(2): R33–R43.
[29]
Galazis N, Olaleye O, Haoula Z,et al. Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration[J]. Fertil Steril,98(6):1590–1601.
[30]
Galazis N, Pang YL, Galazi M,et al. Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration[J]. Gynecol Endocrinol, 2013, 29(7): 638–644.
[31]
Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects[J]. Mol Cell Proteomics,2002,1(11): 845–867.
[1] Hongbin Wang, Hongxia Zhang, Wen He, Lijuan Du, Linggang Cheng, Yukang Zhang, Meng Zhang. Ultrasound and contrast-enhanced ultrasound features of low-grade appendiceal mucinous tumor and appendiceal mucinous adenocarcinoma[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 865-871.
[2] Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[3] Han Zhou, Huwen Wu, Peishen Zhang, Hanbing Deng, Wenxuan Fan, Jiacheng Li, Shaowen Cheng. Research progress of proteomics in chronic non healing wounds[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(06): 536-540.
[4] Yufeng Cui, yijun Lin, Zhimin Wang. Research progress on molecular detection technology of Helicobacter pylori[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(05): 257-262.
[5] Linjuan Zhao, Jie Lv, Wensheng Wang, Demao Ma, Tao Hou. Study on the effect of ultrasound guided resection of stellate and cylindrical lactation preserving areas with staining marks[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 634-637.
[6] Ying Xiong, Jinglai Lin, Qi Bai, Jianming Guo, Shuo Wang. How far is AI from clinical application in automated renal cell carcinoma pathological diagnosis?[J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(06): 535-540.
[7] of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[8] Dawen Zheng, Jiandong Wang. Research progress in adjuvant diagnosis of gallbladder cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 769-773.
[9] Qiusheng Wang. Diagnosis and treatment strategy for benign biliary diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 779-782.
[10] Yuhan Yuan, Shengli Yang. Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 883-888.
[11] Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[12] Hao Li, Qishuai Chen, Fazhu Fei, Ningwei Zhang, Yuandong Li, Shuochen Wang, Bin Ren. Progress in noninvasive diagnosis of liver fibrosis in chronic liver disease[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 863-867.
[13] Ruiyi Tan. Current advances and developments in diagnosis and treatment of small cell osteosarcoma[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(08): 781-784.
[14] Ziyang Wang, Hongbin Wang, Xiaojing Liu. Progress in research of serum markers for diagnosis of alpha-fetoprotein negative hepatocellular carcinoma[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 677-681.
[15] Hui Chen, Zupeng Zou, Tiantian Zhou, Yidan Zhang, Haiping Zhang. Progress in research of dermoscopy in differential diagnosis of erythematous dermatosis on the scalp[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 692-698.
Viewed
Full text


Abstract